Endothelial dysfunction assessed by brachial artery ultrasound in severe sepsis and septic shock

Journal of Critical Care

Volumn 27, Issue 3, 2012, Pages 316.e9-316.e14

  Becker, Leandro ^a   Prado, Karen ^a   Foppa, Murilo ^a   Martinelli, Nidiane ^a   Aguiar, Cynthia ^a   Furian, Thiago ^a   Clausell, Nadine ^a   Rohde, Luis Eduardo ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Endothelial Function; Mortality; Sepsis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LACTIC ACID; NORADRENALIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEASIBILITY STUDY; FEMALE; FLOW MEDIATED VASODILATION; FOLLOW UP; HEART HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SURVIVOR; ULTRASOUND; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 84861186066     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.08.002     Document Type: Article

References (24)

1. American College of Chest Physician Society of critical care medicine Consensus conference Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
2. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
3. Iskit A.B., Guc O. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock. Acta Pharmacol Sin 2003, 24:953-957.
4. Reinhardt K., Bayer O., Brunkhorst F., Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002, 30(Suppl.):S302-S312.
5. Corretti M.C., Anderson T.J., Benjamin E.J., International Brachial Artery Reactivity Task Force, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002, 39:257-265.
6. Quyyumi A.A. Prognostic value of endothelial function. Am J Cardiol 2003, 91(suppl.):19H-24H.
7. Perrone-Filardi P., Cuocolo A., Brevetti G., et al. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol 2005, 96:1337-1341.
8. Wu W.C., Sharma S.C., Choudhary G., et al. Flow-mediated vasodilation predicts the presence and extent of coronary artery disease assessed by stress thallium imaging. J Nucl Cardiol 2005, 12:538-544.
9. Meyer B., Mörtl D., Strecker K., et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005, 46:1011-1018.
10. Witte D.R., Westerink J., de Koning E.J., et al. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?. J Am Coll Cardiol 2005, 45:1987-1993.
11. Gokce N., Keaney J.F., Hunter L.M., et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003, 41:1769-1775.
12. Huang A.L., Silver A.E., Shvenke E., et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 2007, 27:2113-2119.
13. Akcakoyun M., Kargin R., Tanalp A.C., et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study. Coron Artery Dis 2008, 19:337-343.
14. Corrado E., Rizzo M., Coppola G., et al. Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis 2008, 19:139-144.
15. Vaudo G., Marchesi S., Siepi D., et al. Human endothelial impairment in sepsis. Atherosclerosis 2008, 197:747-752.
16. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
17. Reinhart K., Menges T., Gardlund B., et al. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES Study. Crit Care Med 2001, 29:765-769.
18. Brauner J.S., Rohde L.E., Clausell N. Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock. Intensive Care Med 2000, 26:305-313.
19. Mathura K.R., Vollebregt K.C., Boer K., et al. Comparison of OPS imaging to intravital capillaroscopy of nail fold microcirculation. J Appl Physiol 2001, 91:74-78.
20. Lundy D.J., Trzeciak S. Microcirculatory dysfunction in sepsis. Crit Care Clin 2009, 25:721-731.
21. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
22. Davis J.S., Yeo T.W., Thomas J.H., et al. Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care 2009, 13(5):R155.
23. Davis J.S., Yeo T.W., Piera K.A., et al. Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 2010, 14(3):R89.
24. Hamburg N.M., Palmisano J., Larson M.G., et al. Relation of brachial and digital measures of vascular function in the community. The Framingham Heart Study. Hypertension 2011, 57:390-396.